esp | eng
SALVAT News


OTOVEL’s trials published in JAMA

12/27/16

OTOVEL’s trials published in JAMA

On December 22nd, 2016, the well recognized medical journal “JAMA Otolaryngology” published, in its online version, the scientific article of the results of the 2 phase III clinical trials carried out by Laboratorios SALVAT with its novel product OTOVEL® (ciprofloxacin 0.3% plus fluocinolone acetonide 0.025% otic solution). The trials compare the efficacy of OTOVEL against its components (ciprofloxacin alone and fluocinolone alone) in the treatment of Acute Otitis Media with Tympanostomy Tubes, and conclude that OTOVEL is more effective than its components separately, and its administration in children is safe and well tolerated.

The full article is available on the following link:

http://jamanetwork.com/journals/jamaotolaryngology/fullarticle/2593752



Laboratorios SALVAT S.A.
C\ Gall, 30-36 08950 - Esplugues de Llobregat - Barcelona España Tel. +34 933 946 400 Fax. +34 934 732 292 salvat@svt.com
1200 Brickell Avenue, Suite 1950, Miami, FL 33131 (US) Tel. +1 786-528-5273 salvatusa@svt.com